JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD

JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD B. Pharmacy IV PHARMACEUTICAL REGULATORY SCIENCE Previous Question Paper (July - 2023 - R17)

B. Pharmacy | IV | I | R17 | July - 2023

Answer PaperPaper Code: 247AFMaximum Marks: 75Time: 3 Hours

Note: i) Question paper consists of Part A, Part B. ii) Part A is compulsory, which carries 25 marks. In Part A, answer all questions. iii) In Part B, Answer any one question from each unit. Each question carries 10 marks and may have a, b as sub questions.

Part A

125 marks
a

Define clinical development phase in drug discovery.

2 marks

Answer

The clinical development phase refers to the series of human trials conducted after successful preclinical testing to evaluate the safety, efficacy, and therapeutic dosage of a new drug candidate before it is approved for marketing.

b

Define new drug as per CDSCO.

3 marks

Answer

As per CDSCO, a new drug is defined as a drug, including active pharmaceutical ingredients or fixed-dose combinations, that has not been approved by the Licensing Authority in any therapeutic category or has been approved but is proposed to be marketed with modified claims, new dosage forms, or new routes of administration.

c

Define NDA.

2 marks

Answer

Sign in to view the complete answer paper.

d

Explain the scope of para 2 in ANDA submission.

3 marks

Answer

Sign in to view the complete answer paper.

e

Define CTD.

2 marks

Answer

Sign in to view the complete answer paper.

f

What are the advantages of ACTD?

3 marks

Answer

Sign in to view the complete answer paper.

g

What is safety monitoring in clinical trials?

2 marks

Answer

Sign in to view the complete answer paper.

h

Explain the scope of monitors in clinical trials.

3 marks

Answer

Sign in to view the complete answer paper.

i

What is Orange Book?

2 marks

Answer

Sign in to view the complete answer paper.

j

Explain the importance of Purple Book.

3 marks

Answer

Sign in to view the complete answer paper.

Part B

2

Discuss in detail about regulatory overview of Phase III clinical trial.

10 marks

Answer

Sign in to view the complete answer paper.

OR
3

Discuss in detail about clinical development stages.

10 marks

Answer

Sign in to view the complete answer paper.

4

Explain the steps involved in NDA.

10 marks

Answer

Sign in to view the complete answer paper.

OR
5

Discuss in detail about overview of regulatory authorities of European Union.

10 marks

Answer

Sign in to view the complete answer paper.

6

An Indian company plans to export anti-viral drug to US, what are procedures must be followed as per the regulatory requirement.

10 marks

Answer

Sign in to view the complete answer paper.

OR
7

Discuss in detail about ACTD.

10 marks

Answer

Sign in to view the complete answer paper.

8

Discuss in detail about informed consent process and procedures.

10 marks

Answer

Sign in to view the complete answer paper.

OR
9

Discuss in detail about pharmacovigilance and its importance in conducting clinical trials.

10 marks

Answer

Sign in to view the complete answer paper.

10

Explain in detail about various guidelines and regulation, its importance in regulatory concept.

10 marks

Answer

Sign in to view the complete answer paper.

OR
11

Explain the scope of laws and acts and federal register and its importance.

10 marks

Answer

Sign in to view the complete answer paper.

About this paper

This page contains the solved question paper with answers of PHARMACEUTICAL REGULATORY SCIENCE from JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD for B. Pharmacy IV I, July - 2023, R17.

For the question paper without answers, switch to the Question Paper tab.

Other papers in PHARMACEUTICAL REGULATORY SCIENCE

Loading Question Papers

Fetching data from database...